Wasif Riaz, M.D
NPI 1497929319 · Medical Oncology Physician · Sebring, FL
Enrolled with Medicare as Practitioner - Hematology/Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1497929319
- Entity type
- Individual
- Primary specialty
- Medical Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D
- Sex
- Male
- Sole proprietor
- No
- License
- ME119193 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
23,320 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Injection, Fosaprepitant (focinvez), 1 MgJ1434 | 7,200 | $3 |
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 3,392 | $8 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 3,054 | $9 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 2,255 | $124 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 1,430 | $14 |
| Injection of Additional New Drug Or Substance Into Vein96375 | 1,323 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 58 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Lenalidomidebrand: Revlimid | 220 | 30 |
| Prochlorperazine Maleate | 156 | 110 |
| Ondansetronbrand: Ondansetron Odt | 144 | 122 |
| Oxycodone Hcl | 125 | 48 |
| Anastrozole | 123 | 61 |
| Acyclovir | 95 | 37 |
| Letrozole | 94 | 42 |
| Gabapentin |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$4,843 across 235 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-04-22
- Last updated
- 2022-08-17
- Certified
- 2022-08-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.